Medibio Ltd
ASX:MEB

Watchlist Manager
Medibio Ltd Logo
Medibio Ltd
ASX:MEB
Watchlist
Price: 0.02 AUD Market Closed
Market Cap: 122m AUD
Have any thoughts about
Medibio Ltd?
Write Note
MEB
/
Income Statement
/
Revenue

Medibio Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medibio Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medibio Ltd
ASX:MEB
Revenue
AU$963.8k
CAGR 3-Years
1%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Revenue
AU$30m
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Revenue
AU$3.8m
CAGR 3-Years
159%
CAGR 5-Years
40%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Revenue
$43.4m
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
15%
Pro Medicus Ltd
ASX:PME
Revenue
AU$166.3m
CAGR 3-Years
35%
CAGR 5-Years
27%
CAGR 10-Years
28%
Medadvisor Ltd
ASX:MDR
Revenue
AU$122.1m
CAGR 3-Years
45%
CAGR 5-Years
68%
CAGR 10-Years
130%
No Stocks Found

Medibio Ltd
Glance View

Market Cap
122m AUD
Industry
Health Care

Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.

MEB Intrinsic Value
0.001 AUD
Overvaluation 97%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Medibio Ltd's Revenue?
Revenue
963.8k AUD

Based on the financial report for Jun 30, 2023, Medibio Ltd's Revenue amounts to 963.8k AUD.

What is Medibio Ltd's Revenue growth rate?
Revenue CAGR 5Y
-18%

Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Medibio Ltd have been 1% over the past three years , -18% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.